Anika Lifts Low End of Full-Year Revenue Guidance
ANIK has more than doubled off its 52-week low of $9.01.
Summary
Anika raised the bottom of its full-year total revenue range, a modest but real improvement in the outlook. The move follows a strong second quarter — Q2 2026 revenue of $32.6M, up 16% year over year, with a $3.3M profit from continuing operations and gross margin at 65%. The company had already reaffirmed guidance with its Q1 report in April and completed a $15M share repurchase, so this is a tightening of an existing forecast rather than a new story. For a small-cap at roughly $259M market value, the low end of the range is what anchors expectations, and lifting it removes some downside risk from the model. The headline gives no new dollar figures, so the size of the raise is unclear until the full release is read.
At the time of this announcement, ANIK was trading at $18.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $258.7M. The 52-week trading range was $9.01 to $22.88. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.